Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ditazol

Known as: 2,2'-(4,5-Diphenyloxazol-2-ylazanediyl)diethanol, Ditazole, Ethanol, 2,2'-((4,5-diphenyl-2-oxazolyl)imino)bis- 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
BACKGROUND In a retrospective study, antiplatelet therapy has been shown to be associated with a decreased incidence of… Expand
Is this relevant?
1995
1995
Platelets from diabetic patients are hypersensitive to aggregating agents. An imbalance in thromboxane/prostacyclin synthesis has… Expand
Is this relevant?
1988
1988
This paper describes mass spectrometric studies on the metabolism of 4,5-diphenyl-2-bis-(2-hydroxyethyl)-amino-oxazole (ditazole… Expand
Is this relevant?
1984
1984
The in vitro activity of the non-steroidal anti-inflammatory agent Ditazole was investigated in a group of 20 male patients at… Expand
Is this relevant?
1983
1983
A method to induce microthrombi in small mesenteric arteries (phi 15-25 microns) has been developed to study platelet reactions… Expand
Is this relevant?
1980
1980
The effects of acetylsalicylic acid (ASA) indometacin and ditazole on prostacyclin production from rabbit aortic rings were… Expand
Is this relevant?
1978
1978
Effect of ditazole, an inhibitor of platelet aggregation, on a metastasizing tumour in mice 
Is this relevant?
1977
1977
Ditazole (4,5-diphenyl-2-bis-(2-hydroxyethyl)-aminoxazol) inhibits in vivo platelet aggregation induced in mice by intravenous… Expand
Is this relevant?
1977
1977
Ditazole (4,5-diphenyl-2-bis-(2-hydroxyethyl)-aminoxazol) is a new drug shown to inhibit prostaglandin release from rat platelets… Expand
Is this relevant?
1975
1975
The release of PGF1alpha and PGF2alpha from superfused blood platelets was studied by the combined use of two radioimmunoassay… Expand
Is this relevant?